288 related articles for article (PubMed ID: 37594096)
21. Influence of formulation variables on miconazole nitrate-loaded lipid based nanocarrier for topical delivery.
Al-Maghrabi PM; Khafagy ES; Ghorab MM; Gad S
Colloids Surf B Biointerfaces; 2020 Sep; 193():111046. PubMed ID: 32416518
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
[TBL] [Abstract][Full Text] [Related]
23. Development of effective ocular preparations of antifungal agents.
Kaur IP; Rana C; Singh H
J Ocul Pharmacol Ther; 2008 Oct; 24(5):481-93. PubMed ID: 18788998
[TBL] [Abstract][Full Text] [Related]
24. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.
Pandey R; Ahmad Z; Sharma S; Khuller GK
Int J Pharm; 2005 Sep; 301(1-2):268-76. PubMed ID: 16023808
[TBL] [Abstract][Full Text] [Related]
25. Prospective Nanotechnology-Based Strategies for Enhanced Intra- and Transdermal Delivery of Antifungal Drugs.
Lengert EV; Talnikova EE; Tuchin VV; Svenskaya YI
Skin Pharmacol Physiol; 2020; 33(5):261-269. PubMed ID: 33091913
[TBL] [Abstract][Full Text] [Related]
26. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation.
Verma P; Pathak K
Nanomedicine; 2012 May; 8(4):489-96. PubMed ID: 21839053
[TBL] [Abstract][Full Text] [Related]
27. Azole antifungal agents.
Bodey GP
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
[TBL] [Abstract][Full Text] [Related]
28. Topical and systemic antifungal agents.
Bodey GP
Med Clin North Am; 1988 May; 72(3):637-59. PubMed ID: 3280911
[TBL] [Abstract][Full Text] [Related]
29. Terbinafine: novel formulations that potentiate antifungal activities.
Ma Y; Chen X; Guan S
Drugs Today (Barc); 2015 Mar; 51(3):197-208. PubMed ID: 25876563
[TBL] [Abstract][Full Text] [Related]
30. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
31. Nano-emulgel: Emerging as a Smarter Topical Lipidic Emulsion-based Nanocarrier for Skin Healthcare Applications.
Anand K; Ray S; Rahman M; Shaharyar A; Bhowmik R; Bera R; Karmakar S
Recent Pat Antiinfect Drug Discov; 2019; 14(1):16-35. PubMed ID: 31333141
[TBL] [Abstract][Full Text] [Related]
32. Exploiting solid lipid nanoparticles and nanostructured lipid carriers for drug delivery against cutaneous fungal infections.
Araujo VHS; Delello Di Filippo L; Duarte JL; Spósito L; Camargo BAF; da Silva PB; Chorilli M
Crit Rev Microbiol; 2021 Feb; 47(1):79-90. PubMed ID: 33156736
[TBL] [Abstract][Full Text] [Related]
33. Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis.
Hosny KM; Sindi AM; Ali S; Alharbi WS; Hajjaj MS; Bukhary HA; Badr MY; Mushtaq RY; Murshid SSA; Almehmady AM; Bakhaidar RB; Alfayez E; Kurakula M
Drug Deliv; 2022 Dec; 29(1):254-262. PubMed ID: 35014929
[No Abstract] [Full Text] [Related]
34. Lipid-based amphotericin B for the treatment of fungal infections.
Slain D
Pharmacotherapy; 1999 Mar; 19(3):306-23. PubMed ID: 10221369
[TBL] [Abstract][Full Text] [Related]
35. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
36. Econazole nitrate-loaded MCM-41 for an antifungal topical powder formulation.
Ambrogi V; Perioli L; Pagano C; Marmottini F; Moretti M; Mizzi F; Rossi C
J Pharm Sci; 2010 Nov; 99(11):4738-45. PubMed ID: 20845470
[TBL] [Abstract][Full Text] [Related]
37. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
38. Nano-Sized Technologies for Miconazole Skin Delivery.
Firooz A; Namdar R; Nafisi S; Maibach HI
Curr Pharm Biotechnol; 2016; 17(6):524-31. PubMed ID: 26927217
[TBL] [Abstract][Full Text] [Related]
39. Antifungal resistance in superficial mycoses.
Gupta AK; Venkataraman M
J Dermatolog Treat; 2022 Jun; 33(4):1888-1895. PubMed ID: 34132155
[TBL] [Abstract][Full Text] [Related]
40. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
